+462,968.8%
NVDA vs THC
+426.5%
+462,542.3%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.9% | +0.9% | +1.9% | +2.7% |
| 7D | -13.2% | +0.2% | -13.4% | -13.2% |
| 30D | -23.2% | +9.0% | -32.2% | -24.6% |
| 3M | -20.0% | +12.9% | -33.0% | -22.1% |
| 6M | -20.6% | +52.8% | -73.5% | -27.4% |
| YTD | -6.6% | +47.4% | -54.1% | -14.5% |
| 1Y | -9.8% | +47.7% | -57.6% | -17.6% |
| 3Y | +260.5% | +444.7% | -184.2% | +153.2% |
| 5Y | +474.2% | +269.3% | +204.9% | +324.8% |
| 10Y | +7,949.9% | +1,913.5% | +6,036.4% | +3,786.2% |
| All | +462,968.8% | +426.5% | +462,542.3% | +208,334.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling